Stock Analiz

Recursion Pharmaceuticals, Inc. (RXRX) stock forecast and price target

Price $3.19 · data as of November 13, 2026

12-month price target

Average target$7.32
Upside / downside+129.7%
Analysts6
ConsensusBuy
Low $4.00Average $7.32High $10.00

Gold marker: average target · white marker: today’s price ($3.19)

Analyst ratings

Strong buy 2Buy 1Hold 4Sell 0Strong sell 0

Earnings and revenue estimates

PeriodEPS estimateEPS growthRevenue estimate
Current fiscal year
ends December 31, 2026
$-0.88+38.8%$40M
Next fiscal year
ends December 31, 2027
$-0.81+8.2%$44M
Next quarter
ends December 31, 2026
$-0.21+0.8%$8M
Quarter after
ends March 31, 2027
$-0.19+12.5%$6M

Consensus of the analysts covering Recursion Pharmaceuticals, updated daily. In the last 30 days 3 estimates were raised and 1 lowered.

Frequently asked questions

What is the Recursion Pharmaceuticals stock price target?

The average 12-month target from 6 analysts is $7.32, 129.7% above the current price of $3.19 Targets range from $4.00 to $10.00.

Is Recursion Pharmaceuticals a buy according to analysts?

The consensus rating is “Buy” (2 strong buy, 1 buy, 4 hold). Ratings are opinions, not guarantees; this is not investment advice.

How much is Recursion Pharmaceuticals expected to earn?

Analysts expect EPS of $-0.88 for the fiscal year ending December 31, 2026 and $-0.81 the year after.

Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.